Form 8-K · Current report
Equinix 8-K, filed Aug 6, 2026
- Filed
- CIK
- 0001101239
- Accession no.
- 0001104659-26-092009
Summary
Equinix, Inc. issued $2.15 billion of senior notes across three series and its subsidiary Equinix Europe 2 Financing Corporation LLC issued $850 million of 5.250% senior notes due 2031 guaranteed by Equinix, for a combined $3.0 billion of new debt. Europe 2 Finco entered cross-currency swaps to convert the 2031 notes to euros, giving an effective interest rate of approximately 3.95% per annum.
Key points
- Equinix issued $850 million of 5.000% senior notes due 2029, $650 million of 5.500% senior notes due 2033 and $650 million of 5.800% senior notes due 2036.
- The 2031 notes are fully and unconditionally guaranteed by Equinix and were swapped into euros at an effective rate of roughly 3.95%.
- Interest on the notes is payable semi-annually beginning February 15, 2027.
- Upon a change of control triggering event, Equinix and Europe 2 Finco must offer to purchase the applicable notes at 101% of principal plus accrued interest.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events Issuances of $850,000,000 Senior Notes due 2029, $850,000,000 Senior Notes due 2031, $650,000,000 Senior Notes due 2033 and $650,000,000 Senior Notes due 2036 On August 6, 2026, Equinix, Inc. (“Parent”), a Delaware corporation, issued and sold $850,000,000 aggregate principal amount of its 5.000% Senior Notes due 2029 (the “2029 Notes”), $650,000,000 aggregate principal amount of its 5.500% Senior Notes due 2033 (the “2033 Notes”) and $650,000,000 aggregate principal amount of its 5.800% Senior Notes due 2036 (the “2036 Notes”), pursuant to an underwriting agreement dated July 30, 2026, by and among Parent and the several underwriters named in Schedule II thereto. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.